Status:
UNKNOWN
Expanding Pancreas Donor Pool by Evaluation of Unallocated Organs After Brain Death - The EXPLORE Study
Lead Sponsor:
Dr. A. Mehrabi
Collaborating Sponsors:
University Hospital Heidelberg
University Hospital Tuebingen
Conditions:
Unallocated Pancreas Organs
Eligibility:
All Genders
Up to 60 years
Brief Summary
Pancreas graft quality directly affects morbidity and mortality rates after pancreas transplantation (PTx). The criteria for pancreas graft allocation are restricted, which has decreased the number of...
Detailed Description
With advances in surgery and immunosuppressive therapy, PTx has become an accepted and standardized therapeutic surgery worldwide. Today, PTx is a promising treatment for type 1 diabetes mellitus and ...
Eligibility Criteria
Inclusion
- Eligible brain-dead organ donors in Baden-Württemberg with consent to donation
- Pancreas reported to Eurotransplant for allocation by the German Organ Transplantation Foundation
- Age ≤ 60 years old
- BMI ≤ 35
Exclusion
- Pancreases allocated for transplantation
- Pancreases allocated for islet cell transplantation after being assessed not suitable for solid organ transplantation
- History of pancreas disease
- History of pancreas surgery
Key Trial Info
Start Date :
November 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04127266
Start Date
November 1 2019
End Date
November 1 2022
Last Update
December 23 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Division of Visceral Transplantation, Department of General, Visceral and Transplantation Surgery, University of Heidelberg
Heidelberg, Baden-Wurttemberg, Germany, 69120